LANN_STRMG
ID LANN_STRMG Reviewed; 63 AA.
AC O68586;
DT 23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT 01-AUG-1998, sequence version 1.
DT 25-MAY-2022, entry version 62.
DE RecName: Full=Lantibiotic mutacin-1140;
DE AltName: Full=Mutacin III;
DE Flags: Precursor;
GN Name=lanA; Synonyms=mutA;
OS Streptococcus mutans.
OC Bacteria; Firmicutes; Bacilli; Lactobacillales; Streptococcaceae;
OC Streptococcus.
OX NCBI_TaxID=1309;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=JH1005;
RX PubMed=9596742; DOI=10.1128/iai.66.6.2743-2749.1998;
RA Hillman J.D., Novak J., Sagura E., Gutierrez J.A., Brooks T.A.,
RA Crowley P.J., Hess M., Azizi A., Leung K.-P., Cvitkovitch D.,
RA Bleiweis A.S.;
RT "Genetic and biochemical analysis of mutacin 1140, a lantibiotic from
RT Streptococcus mutans.";
RL Infect. Immun. 66:2743-2749(1998).
RN [2]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=UA787;
RX PubMed=10473390; DOI=10.1128/aem.65.9.3880-3887.1999;
RA Qi F., Chen P., Caufield P.W.;
RT "Purification of mutacin III from group III Streptococcus mutans UA787 and
RT genetic analyses of mutacin III biosynthesis genes.";
RL Appl. Environ. Microbiol. 65:3880-3887(1999).
RN [3]
RP PROTEIN SEQUENCE OF 42-63, IDENTIFICATION BY MASS SPECTROMETRY, STRUCTURE
RP BY NMR, DEHYDRATION AT SER-46 AND THR-55, AND LANTHIONINE CROSS-LINKS.
RX PubMed=11082191; DOI=10.1046/j.1432-1033.2000.01777.x;
RA Smith L., Novak J., Rocca J., McClung S., Hillman J.D., Edison A.S.;
RT "Covalent structure of mutacin 1140 and a novel method for the rapid
RT identification of lantibiotics.";
RL Eur. J. Biochem. 267:6810-6816(2000).
CC -!- FUNCTION: Lanthionine-containing peptide antibiotic (lantibiotic)
CC active on Gram-positive bacteria. The bactericidal activity of
CC lantibiotics is based on depolarization of energized bacterial
CC cytoplasmic membranes, initiated by the formation of aqueous
CC transmembrane pores.
CC -!- PTM: Maturation of lantibiotics involves the enzymatic conversion of
CC Thr, and Ser into dehydrated AA and the formation of thioether bonds
CC with cysteine. The C-terminal lanthionine undergoes decarboxylation.
CC This is followed by membrane translocation and cleavage of the modified
CC precursor.
CC -!- PTM: The structure of the 2,3-didehydrobutyrine is not discussed in
CC PubMed:11082191.
CC -!- SIMILARITY: Belongs to the type A lantibiotic family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF051560; AAC18827.1; -; Genomic_DNA.
DR EMBL; AF154675; AAD56142.1; -; Genomic_DNA.
DR RefSeq; WP_002268802.1; NZ_LTAK01000001.1.
DR AlphaFoldDB; O68586; -.
DR TCDB; 1.C.20.1.8; the nisin (nisin) family.
DR GO; GO:0005576; C:extracellular region; IEA:InterPro.
DR GO; GO:0005102; F:signaling receptor binding; IEA:UniProtKB-KW.
DR GO; GO:0019835; P:cytolysis; IEA:UniProtKB-KW.
DR GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR InterPro; IPR006079; Lantibiotic_typ-A_Bacillales.
DR Pfam; PF02052; Gallidermin; 1.
DR PRINTS; PR00323; GALLIDERMIN.
DR TIGRFAMs; TIGR03731; lantibio_gallid; 1.
PE 1: Evidence at protein level;
KW Antibiotic; Antimicrobial; Bacteriocin; D-amino acid;
KW Direct protein sequencing; Lantibiotic; Thioether bond.
FT PROPEP 1..41
FT /evidence="ECO:0000269|PubMed:11082191"
FT /id="PRO_0000017130"
FT PEPTIDE 42..63
FT /note="Lantibiotic mutacin-1140"
FT /id="PRO_0000017131"
FT MOD_RES 46
FT /note="2,3-didehydroalanine (Ser)"
FT /evidence="ECO:0000269|PubMed:11082191"
FT MOD_RES 55
FT /note="2,3-didehydrobutyrine"
FT /evidence="ECO:0000269|PubMed:11082191"
FT CROSSLNK 44..48
FT /note="Lanthionine (Ser-Cys)"
FT /evidence="ECO:0000269|PubMed:11082191"
FT CROSSLNK 49..52
FT /note="Beta-methyllanthionine (Thr-Cys)"
FT /evidence="ECO:0000269|PubMed:11082191"
FT CROSSLNK 57..62
FT /note="Lanthionine (Ser-Cys)"
FT /evidence="ECO:0000269|PubMed:11082191"
FT CROSSLNK 60..63
FT /note="S-(2-aminovinyl)-D-cysteine (Ser-Cys)"
FT /evidence="ECO:0000269|PubMed:11082191"
SQ SEQUENCE 63 AA; 6968 MW; ED9BC73771758489 CRC64;
MSNTQLLEVL GTETFDVQED LFAFDTTDTT IVASNDDPDT RFKSWSLCTP GCARTGSFNS
YCC